FDA Approves Emrelis (telisotuzumab vedotin-tllv) for High c-MET Expressing NSCLC

2025-05-16T08:32:29-05:00May 15th, 2025|Hot Topics, News, Science and Research|

Did you know? There are different kinds of changes, called mutations, that can happen in the MET gene. These changes can help cancer grow and spread. One type is called c-MET overexpression. This means the cancer cells make too [...]